Inhibikase Therapeutics
IKT
IKT
14 hedge funds and large institutions have $2.69M invested in Inhibikase Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 11 reducing their positions, and 6 closing their positions.
Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Edgewood Management
Greenwich,
Connecticut
|
$60.2K |
2 |
2
Barclays
London,
United Kingdom
|
$41K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$7 |